Profund Advisors’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.2M Buy
57,051
+14,302
+33% +$528K 0.08% 181
2025
Q4
$1.52M Buy
42,749
+9,666
+29% +$272K 0.05% 266
2025
Q3
$475K Buy
33,083
+12,926
+64% +$153K 0.02% 533
2025
Q2
$145K Sell
20,157
-14,738
-42% -$81.7K 0.01% 944
2025
Q1
$209K Buy
34,895
+3,306
+10% +$25.9K 0.01% 889
2024
Q4
$246K Buy
31,589
+8,167
+35% +$81.4K 0.01% 876
2024
Q3
$253K Sell
23,422
-11,072
-32% -$108K 0.01% 905
2024
Q2
$291K Sell
34,494
-73,992
-68% -$561K 0.01% 733
2024
Q1
$729K Buy
108,486
+60,917
+128% +$377K 0.03% 447
2023
Q4
$280K Buy
47,569
+14,366
+43% +$110K 0.01% 818
2023
Q3
$324K Sell
33,203
-4,784
-13% -$56.7K 0.02% 628
2023
Q2
$450K Sell
37,987
-7,275
-16% -$83.5K 0.02% 544
2023
Q1
$488K Buy
+45,262
New +$579K 0.03% 510

Other funds holding COGT